tradingkey.logo

10X Genomics Inc

TXG
12.640USD
-0.110-0.86%
終値 10/06, 16:00ET15分遅れの株価
1.57B時価総額
損失額直近12ヶ月PER

10X Genomics Inc

12.640
-0.110-0.86%

詳細情報 10X Genomics Inc 企業名

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

10X Genomics Incの企業情報

企業コードTXG
会社名10X Genomics Inc
上場日Sep 12, 2019
最高経営責任者「CEO」Mr. Serge Wilson Saxonov, Ph.D.
従業員数1306
証券種類Ordinary Share
決算期末Sep 12
本社所在地6230 Stoneridge Mall Road
都市PLEASANTON
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号94588
電話番号19254017300
ウェブサイトhttps://www.10xgenomics.com/
企業コードTXG
上場日Sep 12, 2019
最高経営責任者「CEO」Mr. Serge Wilson Saxonov, Ph.D.

10X Genomics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.06M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
44.69K
-14.35%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
28.62K
+115.82%
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.06M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
44.69K
-14.35%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%

収益内訳

通貨: USD更新時刻: 7 hours ago
通貨: USD更新時刻: 7 hours ago
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Consumables
122.19M
70.66%
Products and services revenue
27.75M
16.05%
Instruments
14.50M
8.38%
Services
8.47M
4.90%
地域別USD
会社名
収益
比率
United States
103.49M
59.85%
Europe, the Middle East and Africa
34.73M
20.09%
China
23.17M
13.40%
Asia Pacific
8.85M
5.12%
Americas
2.67M
1.54%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
122.19M
70.66%
Products and services revenue
27.75M
16.05%
Instruments
14.50M
8.38%
Services
8.47M
4.90%

株主

更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
ARK Investment Management LLC
12.14%
The Vanguard Group, Inc.
10.85%
Fidelity Management & Research Company LLC
6.68%
BlackRock Institutional Trust Company, N.A.
6.63%
Sumitomo Mitsui Trust Bank, Limited
5.26%
他の
58.44%
株主統計
株主統計
比率
ARK Investment Management LLC
12.14%
The Vanguard Group, Inc.
10.85%
Fidelity Management & Research Company LLC
6.68%
BlackRock Institutional Trust Company, N.A.
6.63%
Sumitomo Mitsui Trust Bank, Limited
5.26%
他の
58.44%
種類
株主統計
比率
Investment Advisor
53.51%
Investment Advisor/Hedge Fund
22.37%
Hedge Fund
14.10%
Bank and Trust
6.38%
Research Firm
4.97%
Venture Capital
2.31%
Individual Investor
1.85%
Pension Fund
0.63%
Family Office
0.51%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
662
119.53M
104.47%
-16.69M
2025Q2
669
120.42M
108.39%
-15.20M
2025Q1
687
115.67M
104.27%
-8.84M
2024Q4
689
107.08M
98.92%
-12.41M
2024Q3
682
106.90M
100.39%
-9.08M
2024Q2
691
105.36M
99.70%
-5.09M
2024Q1
762
106.36M
101.17%
-3.12M
2023Q4
817
100.80M
96.01%
-9.73M
2023Q3
835
96.86M
93.80%
-12.55M
2023Q2
857
94.98M
96.77%
-15.37M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
ARK Investment Management LLC
13.89M
12.14%
+1.05M
+8.15%
Jun 30, 2025
The Vanguard Group, Inc.
12.42M
10.85%
+1.32M
+11.92%
Jun 30, 2025
Fidelity Management & Research Company LLC
7.64M
6.68%
-930.78K
-10.85%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
7.58M
6.63%
+2.17M
+40.18%
Jun 30, 2025
Sumitomo Mitsui Trust Bank, Limited
6.02M
5.26%
+654.60K
+12.20%
Jun 30, 2025
AQR Capital Management, LLC
4.14M
3.62%
+2.93M
+241.28%
Jun 30, 2025
BofA Global Research (US)
2.91M
2.54%
+350.99K
+13.74%
Jun 30, 2025
Millennium Management LLC
2.88M
2.52%
-2.65M
-47.89%
Jun 30, 2025
Two Sigma Investments, LP
2.84M
2.48%
-329.64K
-10.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.65M
2.32%
+773.20K
+41.18%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: 16 hours ago
更新時刻: 16 hours ago
銘柄名
比率
ARK Genomic Revolution ETF
4.36%
WisdomTree BioRevolution Fund
2.19%
Global X Genomics & Biotechnology ETF
1.7%
Janus Henderson Small Cap Growth Alpha ETF
1.61%
ARK Innovation ETF
1.38%
Harbor Long-Short Equity ETF
1.06%
Invesco NASDAQ Future Gen 200 ETF
0.59%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.51%
Principal U.S. Small-Cap ETF
0.22%
Vanguard US Quality Factor ETF
0.16%
詳細を見る
ARK Genomic Revolution ETF
比率4.36%
WisdomTree BioRevolution Fund
比率2.19%
Global X Genomics & Biotechnology ETF
比率1.7%
Janus Henderson Small Cap Growth Alpha ETF
比率1.61%
ARK Innovation ETF
比率1.38%
Harbor Long-Short Equity ETF
比率1.06%
Invesco NASDAQ Future Gen 200 ETF
比率0.59%
First Trust Nasdaq Lux Digi Health Solutions ETF
比率0.51%
Principal U.S. Small-Cap ETF
比率0.22%
Vanguard US Quality Factor ETF
比率0.16%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI